Skip to main content
Premium Trial:

Request an Annual Quote

Paul Heaney, Samuel Kaplan

Premium

CalbaTech, which recently acquired oligo and reagent provider Molecula Research Laboratories, said this week that it has appointed Paul Heaney to its scientific advisory board.

Heaney received a PhD in medicinal chemistry from the University of Glasgow, said CalbaTech, and has held senior research and development positions at Amersham International (now Amersham Biosciences), Kodak Clinical Diagnostics (now Ortho-Clinical Diagnostics), Genometrix, Orchid Biosciences, and Sequenom.

Heaney joins former Smith Kline Beecham executive David O’Bryan and Nobel Laureate Kary Mullis on CalbaTech’s scien- tific advisory board, the company added.


CytoGenix announced this week that it has named Samuel Kaplan to its scientific advisory board.

Kaplan is professor and chairman of the department of molecular bio- logy at the University of Texas Houston Medical School and chairman of the publication board of the American Society of Microbiology, said the company. He holds a bachelor’s degree from Cornell University, a masters from Yale, and a PhD in molecular genetics from UC San Diego.

 

The Scan

Rise of BA.5

The New York Times reports that the Omicron subvariant BA.5 has become the dominant version of SARS-CoV-2 in the US.

UK Health Secretary Resigns

Sajid Javid, the UK health secretary, resigned along with Chancellor Rishi Sunak, saying they cannot work with Prime Minister Boris Johnson's government, CNN reports.

Clones From Freeze-Dried Cells

A team in Japan has cloned mice from freeze-dried skin cells, according to the Guardian.

Genome Research Papers on Craniosynostosis, Macaque Retrotransposition, More

In Genome Research this week: structural variants in craniosynostosis, LINE-1 activity in rhesus macaque brain, and more.